Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification

被引:1
|
作者
Bae, Bong Kyung [1 ]
Cho, Won Kyung [1 ]
Kim, Byoung-Gie [2 ]
Choi, Chel Hun [2 ]
Kim, Tae-Joong [2 ]
Lee, Yoo-Young [2 ]
Lee, Jeong-Won [2 ]
Park, Won [1 ]
机构
[1] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
关键词
Adenocarcinoma; Pathology; PELVIC RADIATION-THERAPY; RADICAL HYSTERECTOMY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; UTERINE CERVIX; CARCINOMA; CANCER; CLASSIFICATION; INVASION;
D O I
10.1136/ijgc-2022-003971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCervical adenocarcinoma has poorer outcomes compared with squamous cell carcinoma; however, treatment is identical irrespective of histologic sub-types. This study aimed to investigate the patterns and risk factors of recurrence following surgery alone for low-risk early-stage cervical adenocarcinoma. MethodsWe retrospectively reviewed patients who underwent surgery alone for low-risk early-stage cervical adenocarcinoma between January 2001 and December 2018 in a single institution. Baseline clinicopathological characteristics were collected to identify the factors associated with recurrence-free survival. ResultsA total of 252 patients met the inclusion criteria. Most patients underwent radical hysterectomy (218 patients, 86.5%) and had usual type endocervical adenocarcinoma (190 patients, 75.4%). The International Federation of Gynecology and Obstetrics 2018 stage was IA1 in 72 patients (27.4%), IA2 in 58 (22.1%), IB1 in 51 (19.4%), and IB2 in 71 patients (27.0%). With a median follow-up of 70.4 months (range 6.2-252.5 months), 5-year survival rates were as follows: locoregional recurrence-free survival, 93.0%; recurrence-free survival, 89.6%; overall survival, 94.7%. The recurrence patterns were local in nine patients (32.1%), regional in five patients (17.8%), distant in 10 patients (35.7%), local and distant in one patient (3.6%), regional and distant in two patients (7.2%), and locoregional and distant in one patient (3.6%). In multivariable analysis, negative human papillomavirus (HPV) status (HR 7.314; p<0.001) and deep cervical stromal invasion (HR 5.110; p=0.003) were associated with poor locoregional recurrence-free survival. Patients were stratified based on the number of risk factors and a statistically significant difference in locoregional recurrence-free survival was observed: 5-year survival rates of 99.0%, 84.2%, and 50.0% for patients with 0, 1, and 2 risk factors (0 vs 1, p=0.001; 1 vs 2, p=0.011). ConclusionSurgery alone for low-risk early-stage cervical adenocarcinoma was associated with favorable outcomes over a long follow-up period. Patients with the highest risk of recurrence were those with a negative HPV status and deep cervical stromal invasion. Additional management following surgery may be considered in patients with these risk factors.
引用
收藏
页码:1524 / 1530
页数:7
相关论文
共 50 条
  • [1] Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern
    Bae, Bong Kyung
    Bae, Hyunsik
    Cho, Won Kyung
    Kim, Byoung-Gie
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Yoo-Young
    Lee, Jeong-Won
    Kim, Hyun-Soo
    Park, Won
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2024, 43 (05) : 447 - 456
  • [2] Impact of preoperative leukocyte alteration in surgically-treated early-stage cervical cancer patients with low-risk, intermediate-risk or high-risk factors
    Matsumoto, Y.
    Mabuchi, S.
    Kozasa, K.
    Kuroda, H.
    Sasano, T.
    Yokoi, E.
    Sawada, K.
    Kimura, T.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (06) : 939 - 946
  • [3] Parametrial involvement in women with low-risk, early-stage cervical cancer
    Vanichtantikul, A.
    Tantbirojn, P.
    Manchana, T.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (05)
  • [4] Defining low-risk lesions in early-stage esophageal adenocarcinoma
    Sihag, Smita
    De La Torre, Sergio
    Hsu, Meier
    Nobel, Tamar
    Tan, Kay See
    Gerdes, Hans
    Shah, Pari
    Bains, Manjit
    Jones, David R.
    Molena, Daniela
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (04) : 1272 - 1279
  • [5] Utility of risk-weighted surgical-pathological factors in early-stage cervical cancer
    Matsuo, K.
    Mabuchi, S.
    Okazawa, M.
    Matsumoto, Y.
    Tsutsui, T.
    Fujita, M.
    Kamiura, S.
    Ogawa, K.
    Morrow, C. P.
    Kimura, T.
    BRITISH JOURNAL OF CANCER, 2013, 108 (06) : 1348 - 1357
  • [6] Outcomes of patients with intermediate risk early stage cervical adenocarcinoma - a single institution experience
    Jonska-Gmyrek, J.
    Zolciak-Siwinska, A.
    Kotowicz, B.
    Gmyrek, L.
    Fuksiewicz, M.
    Michalski, W.
    Leibschang, J.
    Kowalska, M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2018, 39 (04) : 600 - 603
  • [7] Risk Stratification of Early-Stage Cervical Cancer with Intermediate-Risk Factors: Model Development and Validation Based on Machine Learning Algorithm
    Chu, Ran
    Zhang, Yue
    Qiao, Xu
    Xie, Lin
    Chen, Wei
    Zhao, Ying
    Xu, Yintao
    Yuan, Zeng
    Liu, Xiaolin
    Yin, Aijun
    Wang, Zhiwen
    Zhang, Qing
    Yang, Xingsheng
    Su, Xuantao
    Kong, Beihua
    Song, Kun
    ONCOLOGIST, 2021, 26 (12) : E2217 - E2226
  • [8] Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
    Park, Jeong-Yeol
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (02)
  • [9] Vaginal Radical Trachelectomy for Early-Stage Cervical Cancer: Increased Recurrence Risk for Adenocarcinoma
    Zusterzeel, Petra L. M.
    Pol, Fraukje J. M.
    van Ham, Maaike
    Zweemer, Ronald P.
    Bekkers, Ruud L. M.
    Massuger, Leon F. A. G.
    Verheijen, Rene H. M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (07) : 1293 - 1299
  • [10] Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
    Matsuo, Koji
    Mabuchi, Seiji
    Okazawa, Mika
    Kawano, Mahiru
    Kuroda, Hiromasa
    Kamiura, Shoji
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (01) : 3 - 11